Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali M Harandi

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Ebiomedicine|March 25, 2018
Vaccine Biomarkers: In Search of a Goldilocks ApproachAli M Harandi
Seminars in Immunology|August 21, 2018
Systems analysis of human vaccine adjuvantsAli M Harandi
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2004
The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challengesAli M Harandi
Current HIV Research|April 1, 2010
Mucosal adjuvantsAli M Harandi, Donata Medaglini
Vaccine|July 11, 2006
CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tacticsAli M Harandi, Jan Holmgren
Journal of Reproductive Immunology|October 20, 2007
Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in miceSara Tengvall, Ali M Harandi
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infectionsAli M Harandi, Jan Holmgren
Immunology and Cell Biology|July 28, 2010
'Help' from an unexpected source: polyclonal Tregs enhance antibody response to mucosal immunizationSukanya Raghavan, Ali M Harandi
Expert Review of Vaccines|October 11, 2008
4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (adjuvant 2008)Oliver Pérez, Ali M Harandi
Expert Review of Vaccines|August 6, 2003
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Ali M Harandi, Cecil Czerkinsky
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Ebiomedicine|March 25, 2018
Vaccine Biomarkers: In Search of a Goldilocks ApproachAli M Harandi
Seminars in Immunology|August 21, 2018
Systems analysis of human vaccine adjuvantsAli M Harandi
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2004
The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challengesAli M Harandi
Current HIV Research|April 1, 2010
Mucosal adjuvantsAli M Harandi, Donata Medaglini
Vaccine|July 11, 2006
CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tacticsAli M Harandi, Jan Holmgren
Journal of Reproductive Immunology|October 20, 2007
Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in miceSara Tengvall, Ali M Harandi
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infectionsAli M Harandi, Jan Holmgren
Immunology and Cell Biology|July 28, 2010
'Help' from an unexpected source: polyclonal Tregs enhance antibody response to mucosal immunizationSukanya Raghavan, Ali M Harandi
Expert Review of Vaccines|October 11, 2008
4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (adjuvant 2008)Oliver Pérez, Ali M Harandi
Expert Review of Vaccines|August 6, 2003
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAJan Holmgren, Ali M Harandi, Cecil Czerkinsky
Pageof 8